Michael Regan, Equity Research Analyst


Comp Tables as of Feb. 24, 2020: Multiples compress

February 25, 2020 · Updated March 3, 2020

These comp tables provide a benchmark for private investors to evaluate existing and future investments, a way for companies to judge their own valuations for current and future capital raises as well as a menu for public investors to peruse.

Read Article

Comp tables as of Feb. 10: Estimates and multiples drop

February 11, 2020

Average trading multiples for U.S.-focused operators are 2.5X 2020 sales and 12.5X 2020 EBITDA, down from last week’s 2.6X and 13.4X, respectively. The big changes are that consensus revenue expectations dropped for Harvest Health & Recreation (-8% for 2020 and 13% for 2021) and Curaleaf (-2% for 2020 and -8% for 2021). Canada-focused operators still […]

Read Article